Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bristol-myers squibb company crawled date : 2021 - 05 - 20 save search
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
Published: 2021-05-20 (Crawled : 22:00) - biospace.com/
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: -0.35%
H: 2.92%
C: 2.57%
food treatment therapy cancer drug iot nivolumab
FDA approves nivolumab for resected esophageal or GEJ cancer
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
fda cancer approval fda approval nivolumab
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
PFE A | $25.73 -0.7% 17M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | $749.215 -0.21% 1.4M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.385 0.34% 110K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | $162.93 0.78% 3.1M
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.09 1.21% 370K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $11.125 0.5% 40K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | $46.05 -0.41% 940K
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.13 -1.74% 520K
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | $895.92 -0.29% 310K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.17 1.3% 780K
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $53.725 0.55% 630K
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $118.275 -2.38% 1M
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL 4 | $22.965 1.17% 630K
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | $87.89 3.18% 220K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE S | $134.185 -3.05% 150K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | $147.495 -0.14% 110K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | $29.11 -0.51% 270K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Intensity Therapeutics Announces Two Abstracts to Be Presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2021-05-20 (Crawled : 13:15) - biospace.com/
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: -0.35%
H: 2.92%
C: 2.57%
Bristol Myers Squibb Elects Manuel Hidalgo Medina, M.D., Ph.D. to Board of Directors
Published: 2021-05-20 (Crawled : 12:00) - biospace.com/
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: -0.35%
H: 2.92%
C: 2.57%
AGEN 4 | $6.875 5.77% 680K
|
Health Technology
|
| O: -0.6%
H: 5.9%
C: 0.6%
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
TPET | $0.5189 124.54% 38M
|
n/a
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
PALI | $5.51 32.45% 28M
|
Manufacturing
VERO | $0.804 31.8% 110K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.